Monday - February 9, 2026
Pfizer Aims to Bring Imperial Obesity Drug Candidates to Clinic in $4.9bn Deal
October 09, 2025
LONDON, England, Oct. 9 -- Imperial College-London issued the following news:

* * *

Pfizer aims to bring Imperial obesity drug candidates to clinic in $4.9bn deal

Multinational bets on candidates invented by GLP-1 pioneer Professor Steve Bloom to propel it into the race for next-generation obesity treatments.

By David Silverman

Pfizer has announced an agreement to acquire US biotechnology startup Metsera at a $4.9 billion valuation . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products